Feeder-Free Avian Stem Cell Culture for Pure Telencephalic Organoids
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The production of avian embryonic stem cells is traditionally dependent on feeder cells, which increases costs, impairs scale-up, and results in mixed cell populations, making it challenging to achieve pure stem cell cultures.
Innovation Solution
Culturing epiblast cells from stage IX-XI avian embryos in a feeder-free cell culture medium containing specific growth factors and inhibitors, such as FGF-2, MEK/ERK pathway inhibitors, TGF-β type I receptor signaling inhibitors, and GSK-3 inhibitors, in a glycoprotein-coated container to maintain pluripotency and prevent differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If feeder cells are used in traditional avian stem cell culture, then cell survival and proliferation are maintained, but production costs increase, scale-up is impaired, and cell population purity decreases
Solution Approach 1:
The patent removes feeder cells from the culture system entirely, replacing them with a chemically defined medium containing specific growth factors and inhibitors. This extraction of the feeder cell component eliminates the complexity associated with maintaining feeder cell layers while preserving stem cell viability through alternative biochemical signals.
Solution Approach 2:
The patent introduces an intermediary culture system using glycoprotein-coated surfaces (such as laminin or fibronectin) that mediate cell attachment and survival without requiring living feeder cells. This intermediary layer provides the necessary physical and biochemical cues for stem cell maintenance while avoiding the complications of feeder cell dependency.
2Adaptability or versatility
If feeder cells are used in traditional avian stem cell culture, then cell population heterogeneity is maintained, but obtaining pure stem cell cultures becomes difficult
Solution Approach 1:
By removing feeder cells from the culture system, the patent eliminates the source of cellular heterogeneity that feeders introduce. This allows for the derivation of pure avian stem cell populations without contamination from feeder cell types, enabling precise manipulation and study of homogeneous stem cell cultures.
Solution Approach 2:
The patent creates a specialized local culture environment with specific growth factors and inhibitors tailored to maintain avian stem cell pluripotency. This localized biochemical environment selectively supports stem cell survival while preventing differentiation or contamination from other cell types, ensuring population purity.
3Productivity
If feeder-free culture methods are implemented, then production costs decrease and scale-up becomes feasible, but maintaining stem cell pluripotency becomes more challenging
Solution Approach 1:
The patent systematically optimizes multiple cultural parameters including growth factor concentrations (such as FGF-2), inhibitor levels (such as MEK inhibitors), and medium composition to achieve feeder-free maintenance of avian stem cells. By carefully adjusting these parameters, the system achieves both scalability and pluripotency maintenance without feeder cells.
Solution Approach 2:
The patent employs a composite culture medium containing multiple components including growth factors, inhibitors, and glycoprotein coatings that work synergistically to maintain stem cell pluripotency in feeder-free conditions. This composite approach combines multiple biochemical signals to replicate the complex environment previously provided by feeder cells.
Data Source
AI summary
Provided are methods of producing avian embryonic stem cells. In certain embodiments, the methods comprise culturing epiblast cells obtained from a stage IX-XI avian embryo in a cell culture medium present in a feeder-free cell culture container. Also provided are methods of producing two-dimension cultures, spheroids, or organoids from the avian embryonic stem cells produced according to the methods. For example, provided are methods of producing avian telencephalic organoids from the avian embryonic stem cells. Also provided are methods of using the avian embryonic stem cells, spheroids and organoids produced according to the methods of the present disclosure. For example, provided are screening methods comprising contacting the avian embryonic stem cells, spheroids or organoids with a test agent, and assessing for an effect of the test agent on the avian embryonic stem cells, spheroids or organoids.